These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 35033490)

  • 1. Prevalence and Prognostic Significance of Microvascular Dysfunction in Heart Failure With Preserved Ejection Fraction.
    Arnold JR; Kanagala P; Budgeon CA; Jerosch-Herold M; Gulsin GS; Singh A; Khan JN; Chan DCS; Squire IB; Ng LL; McCann GP
    JACC Cardiovasc Imaging; 2022 Jun; 15(6):1001-1011. PubMed ID: 35033490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship Between Focal and Diffuse Fibrosis Assessed by CMR and Clinical Outcomes in Heart Failure With Preserved Ejection Fraction.
    Kanagala P; Cheng ASH; Singh A; Khan JN; Gulsin GS; Patel P; Gupta P; Arnold JR; Squire IB; Ng LL; McCann GP
    JACC Cardiovasc Imaging; 2019 Nov; 12(11 Pt 2):2291-2301. PubMed ID: 30772227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency of Coronary Microvascular Dysfunction and Diffuse Myocardial Fibrosis (Measured by Cardiovascular Magnetic Resonance) in Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction.
    Löffler AI; Pan JA; Balfour PC; Shaw PW; Yang Y; Nasir M; Auger DA; Epstein FH; Kramer CM; Gan LM; Salerno M
    Am J Cardiol; 2019 Nov; 124(10):1584-1589. PubMed ID: 31575425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of right ventricular dysfunction and prognostic significance in heart failure with preserved ejection fraction.
    Kanagala P; Arnold JR; Singh A; Khan JN; Gulsin GS; Gupta P; Squire IB; Ng LL; McCann GP
    Int J Cardiovasc Imaging; 2021 Jan; 37(1):255-266. PubMed ID: 32737707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic and prognostic utility of cardiovascular magnetic resonance imaging in heart failure with preserved ejection fraction - implications for clinical trials.
    Kanagala P; Cheng ASH; Singh A; McAdam J; Marsh AM; Arnold JR; Squire IB; Ng LL; McCann GP
    J Cardiovasc Magn Reson; 2018 Jan; 20(1):4. PubMed ID: 29321034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocardial fibrosis and prognosis in heart failure with preserved ejection fraction: a pooled analysis of 12 cohort studies.
    Zhang X; Yang S; Hao S; Li J; Qiu M; Chen H; Huang Y
    Eur Radiol; 2024 Mar; 34(3):1854-1862. PubMed ID: 37658896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of Coronary Artery Disease and Coronary Microvascular Dysfunction in Patients With Heart Failure With Preserved Ejection Fraction.
    Rush CJ; Berry C; Oldroyd KG; Rocchiccioli JP; Lindsay MM; Touyz RM; Murphy CL; Ford TJ; Sidik N; McEntegart MB; Lang NN; Jhund PS; Campbell RT; McMurray JJV; Petrie MC
    JAMA Cardiol; 2021 Oct; 6(10):1130-1143. PubMed ID: 34160566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations and prognostic significance of diffuse myocardial fibrosis by cardiovascular magnetic resonance in heart failure with preserved ejection fraction.
    Roy C; Slimani A; de Meester C; Amzulescu M; Pasquet A; Vancraeynest D; Beauloye C; Vanoverschelde JL; Gerber BL; Pouleur AC
    J Cardiovasc Magn Reson; 2018 Aug; 20(1):55. PubMed ID: 30086783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction.
    Kanagala P; Arnold JR; Cheng ASH; Singh A; Khan JN; Gulsin GS; Yang J; Zhao L; Gupta P; Squire IB; Ng LL; McCann GP
    Int J Cardiovasc Imaging; 2020 Jan; 36(1):101-110. PubMed ID: 31401742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of quantitative assessment of focal myocardial fibrosis in patients with heart failure with preserved ejection fraction.
    Kato S; Saito N; Kirigaya H; Gyotoku D; Iinuma N; Kusakawa Y; Iguchi K; Nakachi T; Fukui K; Futaki M; Iwasawa T; Taguri M; Kimura K; Umemura S
    Int J Cardiol; 2015 Jul; 191():314-9. PubMed ID: 26005800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intra-study and inter-technique validation of cardiovascular magnetic resonance imaging derived left atrial ejection fraction as a prognostic biomarker in heart failure with preserved ejection fraction.
    Kanagala P; Arnold JR; Singh A; Khan JN; Gulsin GS; Gupta P; Squire IB; Ng LL; McCann GP
    Int J Cardiovasc Imaging; 2020 May; 36(5):921-928. PubMed ID: 32030576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcomes prediction in diabetic heart failure with preserved ejection fraction by cardiac MRI.
    Yang W; Zhu L; He J; Wu W; Zhang Y; Zhuang B; Xu J; Zhou D; Wang Y; Liu G; Sun X; Zhang Q; Sirajuddin A; Arai AE; Zhao S; Lu M
    Eur Radiol; 2024 Sep; 34(9):5678-5690. PubMed ID: 38421414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impairment of Coronary Flow Reserve Evaluated by Phase Contrast Cine-Magnetic Resonance Imaging in Patients With Heart Failure With Preserved Ejection Fraction.
    Kato S; Saito N; Kirigaya H; Gyotoku D; Iinuma N; Kusakawa Y; Iguchi K; Nakachi T; Fukui K; Futaki M; Iwasawa T; Kimura K; Umemura S
    J Am Heart Assoc; 2016 Feb; 5(2):. PubMed ID: 26908404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocardial contrast echocardiography evaluation of coronary microvascular dysfunction to Predict MACEs in patients with heart failure with preserved ejection fraction follow-up.
    Chen F; Weng W; Yang D; Wang X; Zhou Y
    BMC Cardiovasc Disord; 2024 Sep; 24(1):496. PubMed ID: 39289634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diffuse right ventricular fibrosis in heart failure with preserved ejection fraction and pulmonary hypertension.
    Patel RB; Li E; Benefield BC; Swat SA; Polsinelli VB; Carr JC; Shah SJ; Markl M; Collins JD; Freed BH
    ESC Heart Fail; 2020 Feb; 7(1):253-263. PubMed ID: 31903694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coronary microvascular rarefaction and myocardial fibrosis in heart failure with preserved ejection fraction.
    Mohammed SF; Hussain S; Mirzoyev SA; Edwards WD; Maleszewski JJ; Redfield MM
    Circulation; 2015 Feb; 131(6):550-9. PubMed ID: 25552356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporal Relation Between Myocardial Fibrosis and Heart Failure With Preserved Ejection Fraction: Association With Baseline Disease Severity and Subsequent Outcome.
    Schelbert EB; Fridman Y; Wong TC; Abu Daya H; Piehler KM; Kadakkal A; Miller CA; Ugander M; Maanja M; Kellman P; Shah DJ; Abebe KZ; Simon MA; Quarta G; Senni M; Butler J; Diez J; Redfield MM; Gheorghiade M
    JAMA Cardiol; 2017 Sep; 2(9):995-1006. PubMed ID: 28768311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbohydrate antigen 125: a useful marker of congestion, fibrosis, and prognosis in heart failure with preserved ejection fraction.
    Menghoum N; Badii MC; Deltombe M; Lejeune S; Roy C; Vancraeynest D; Pasquet A; Gerber BL; Horman S; Gruson D; Beauloye C; Pouleur AC
    ESC Heart Fail; 2024 Jun; 11(3):1493-1505. PubMed ID: 38339764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heart Failure with Normal Natriuretic Peptide Levels and Preserved Ejection Fraction: A Prospective Clinical and Cardiac MRI Study.
    He J; Yang W; Wu W; Yin G; Zhuang B; Xu J; Zhou D; Zhang J; Wang Y; Zhu L; Sun X; Sirajuddin A; Teng Z; Kureshi F; Arai AE; Zhao S; Lu M
    Radiol Cardiothorac Imaging; 2024 Jun; 6(3):e230281. PubMed ID: 38695743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocardial Native T
    Omori T; Nakamori S; Fujimoto N; Ishida M; Kitagawa K; Ichikawa Y; Kumagai N; Kurita T; Imanaka-Yoshida K; Hiroe M; Sakuma H; Ito M; Dohi K
    JACC Cardiovasc Imaging; 2020 Oct; 13(10):2117-2128. PubMed ID: 32771571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.